SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-030009
Filing Date
2023-11-02
Accepted
2023-11-02 16:16:12
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20230930_10q.htm   iXBRL 10-Q 1468683
2 EXHIBIT 31.1 ex_564415.htm EX-31.1 16165
3 EXHIBIT 31.2 ex_564416.htm EX-31.2 16586
4 EXHIBIT 32.1 ex_564417.htm EX-32.1 12879
10 figure1.jpg GRAPHIC 95844
  Complete submission text file 0001437749-23-030009.txt   6859446

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20230930.xsd EX-101.SCH 59631
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20230930_cal.xml EX-101.CAL 47190
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20230930_def.xml EX-101.DEF 392196
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20230930_lab.xml EX-101.LAB 359108
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20230930_pre.xml EX-101.PRE 422538
64 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20230930_10q_htm.xml XML 1038907
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 231372526
SIC: 2836 Biological Products, (No Diagnostic Substances)